Last reviewed · How we verify

Epinephrine concentration of 1:500000

Al-Azhar University · Phase 3 active Small molecule

Epinephrine concentration of 1:500000 is a Catecholamine; alpha and beta-adrenergic agonist Small molecule drug developed by Al-Azhar University. It is currently in Phase 3 development for Adjunct to local anesthetics to prolong duration and reduce systemic toxicity, Emergency treatment of anaphylaxis, Acute hypotension and shock.

Epinephrine is a catecholamine that binds to alpha and beta adrenergic receptors, causing vasoconstriction, increased heart rate, and bronchodilation.

Epinephrine is a catecholamine that binds to alpha and beta adrenergic receptors, causing vasoconstriction, increased heart rate, and bronchodilation. Used for Adjunct to local anesthetics to prolong duration and reduce systemic toxicity, Emergency treatment of anaphylaxis, Acute hypotension and shock.

At a glance

Generic nameEpinephrine concentration of 1:500000
SponsorAl-Azhar University
Drug classCatecholamine; alpha and beta-adrenergic agonist
TargetAlpha-1 adrenergic receptor; Alpha-2 adrenergic receptor; Beta-1 adrenergic receptor; Beta-2 adrenergic receptor
ModalitySmall molecule
Therapeutic areaAnesthesia; Cardiovascular; Respiratory
PhasePhase 3

Mechanism of action

Epinephrine acts as both an alpha-1 and beta-adrenergic agonist. At the concentration of 1:500,000 (0.002 mg/mL), it is typically used as an adjunct to local anesthetics to prolong anesthetic effect and reduce systemic absorption through vasoconstriction. The drug increases cardiac output, elevates blood pressure, and relaxes bronchial smooth muscle.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Epinephrine concentration of 1:500000

What is Epinephrine concentration of 1:500000?

Epinephrine concentration of 1:500000 is a Catecholamine; alpha and beta-adrenergic agonist drug developed by Al-Azhar University, indicated for Adjunct to local anesthetics to prolong duration and reduce systemic toxicity, Emergency treatment of anaphylaxis, Acute hypotension and shock.

How does Epinephrine concentration of 1:500000 work?

Epinephrine is a catecholamine that binds to alpha and beta adrenergic receptors, causing vasoconstriction, increased heart rate, and bronchodilation.

What is Epinephrine concentration of 1:500000 used for?

Epinephrine concentration of 1:500000 is indicated for Adjunct to local anesthetics to prolong duration and reduce systemic toxicity, Emergency treatment of anaphylaxis, Acute hypotension and shock.

Who makes Epinephrine concentration of 1:500000?

Epinephrine concentration of 1:500000 is developed by Al-Azhar University (see full Al-Azhar University pipeline at /company/al-azhar-university).

What drug class is Epinephrine concentration of 1:500000 in?

Epinephrine concentration of 1:500000 belongs to the Catecholamine; alpha and beta-adrenergic agonist class. See all Catecholamine; alpha and beta-adrenergic agonist drugs at /class/catecholamine-alpha-and-beta-adrenergic-agonist.

What development phase is Epinephrine concentration of 1:500000 in?

Epinephrine concentration of 1:500000 is in Phase 3.

What are the side effects of Epinephrine concentration of 1:500000?

Common side effects of Epinephrine concentration of 1:500000 include Tachycardia, Hypertension, Tremor, Anxiety, Headache, Palpitations.

What does Epinephrine concentration of 1:500000 target?

Epinephrine concentration of 1:500000 targets Alpha-1 adrenergic receptor; Alpha-2 adrenergic receptor; Beta-1 adrenergic receptor; Beta-2 adrenergic receptor and is a Catecholamine; alpha and beta-adrenergic agonist.

Related